Physician
Hematology
Dr. Naveen Pemmaraju, MD
|
|
Give Review
Naveen Pemmaraju works in the field of Hematology. He went to University of Arkansas for Medical Sciences College of Medicine. University of Arkansas for Medical Sciences College of Medicine has a rank of 83 in research and a 35 in primary care Naveen Pemmaraju is also a published doctor. He has 50 publication published. The most recent publication is: Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML). Naveen Pemmaraju, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B-cell Acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations.
- Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal ...
- A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed Acute myeloid leukemia and high-risk myelodysplastic syndrome.
- Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML).
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive Acute lymphoblastic leukaemia: a single-centre, phase...
- Healing words.
- Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis -TAFRO Syndrome.
- Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed Acute myeloid leukemia and Acute lymphoblastic leukemia.
- Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in Acute myeloid ...
- Acute myeloid leukemia with t(10;11): a pathological entity with distinct clinical presentation.
- Identification of a novel fusion gene, IRF2BP2-RARA, in Acute promyelocytic leukemia.
- Characteristics of Sweet Syndrome in Patients With Acute Myeloid Leukemia.
- Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory Acute lymphoblastic leukemia.
- Clinical characteristics and outcomes in patients with Acute promyelocytic leukaemia and hyperleucocytosis.
- A Phase I/II Study of the Janus Kinase (JAK)1 and 2 Inhibitor Ruxolitinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia.
- Phase II study of pomalidomide in combination with prednisone in patients with myelofibrosis and significant Anemia.
- Improving Outcomes for Patients with Acute Myeloid Leukemia in First Relapse: A Single Center Experience.
- Clinical significance of microcytosis in patients with primary myelofibrosis.
- Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of Acute myeloid leukemia.
- Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with Acute lymphoblastic leukemia (ALL).
- Activity of SL-401, a targeted therapy directed to the interleukin-3 receptor, in patients with blastic plasmacytoid dendritic Cell neoplasm.
- Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum, and Blastoschizomyces capitatus) in a patient with Acute myeloid leukemia.
- Update on the Biology and Treatment Options for Hairy Cell Leukemia.
- Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with Acute myeloid leukemia treated with hypomethylating agents.
- Extramedullary B Lymphoblastic Leukemia/Lymphoma (B-ALL/B-LBL): A Diagnostic Challenge.
- Prognostic Implications of Chromosome 17 Abnormalities in the Context of Monosomal Karyotype in Patients With Acute Myeloid Leukemia and Complex Cytogenetics.
- Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy.
- Imatinib therapy in a patient with suspected chronic neutrophilic Leukemia and FIP1L1-PDGFRA rearrangement.
- The combination of Hyper-CVAD plus nelarabine as frontline therapy in adult T cell Acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (LL)-MD Anderson c...
- Primary autoimmune myelofibrosis (MF) with high-grade peripheral T-cell Lymphoma (PTCL) NOS.
- Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy.
- Outcomes in patients with relapsed or refractory Acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.
- TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic Cell neoplasm in the bone marrow.
- Biological and Clinical Features of Trisomy 21 in Adult Patients With Acute Myeloid Leukemia.
- Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤ 60 years with newly diagnosed Acute myeloid leukemia (AML).
- Clinical characteristics and outcomes of therapy-related chronic myelomonocytic Leukemia.
- Ocular granulocytic sarcoma: a case report and literature review of ocular extramedullary Acute myeloid leukemia.
- Is Acute myeloid leukemia a liquid tumor?
- Analysis of outcomes in adolescents and young adults with chronic myelogenous Leukemia treated with upfront tyrosine kinase inhibitor therapy.
- Retrospective review of male breast Cancer patients: analysis of tamoxifen-related side-effects.
- Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Revie...
- A single case of rosai-dorfman Disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine.
- Chronic myeloid Leukemia in adolescents and young adults: patient characteristics, outcomes and review of the literature.
- Extramedullary Acute myeloid leukemia: leukemic pleural effusion, case report and review of the literature.
- FLT3 inhibitors in the treatment of Acute myeloid leukemia: the start of an era?
- Sex differences in the JAK2 V617F allele burden in Chronic myeloproliferative disorders.
- Solifenacin-induced small bowel pseudo-obstruction.
- The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis.
- An absorbing problem.
Schools
Univ Of Ar Coll Of Med
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Texas Health Science Center -
Johns Hopkins University -
University of Arkansas for Medical Sciences College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1578618161 | |
| NPPES Provider LastName | PEMMARAJU | |
| NPPES Provider FirstName | NAVEEN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 440.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 5.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578618161 |
| Last Name Of The Provider | PEMMARAJU |
| First Name Of The Provider | NAVEEN |
| View All |
Similar Doctors
|
|
Dr. Vilmos A. Thomazy, MD |
|
|
Dr. William C. Pugh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil M. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yvonne H. Sada, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mohammad Riaz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yasuhiro Oki, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sumit K. Subudhi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward C. Lynch, MD |
|
|
Dr. Julie A. Ellerhorst, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Chung C. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bonnie S. Glisson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Elias J. Jabbour, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. George R. Blumenschein Jr., MD |
|
|
Dr. Courtney N. Miller-Chism, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wei Lin, MD |
|
|
Dr. Lixin Zhang, MD |
|
Dr. Ronjay Rakkhit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir A. Rasheed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan A. Yates, MD |